HEALTHSEMAFOR
FDA approves cholesterol pill from Merck
The FDA approved Merck's Lipfendra, a cholesterol-lowering pill that outperforms traditional statins and offers an easier alternative to injectable treatments. The approval could improve heart disease prevention, with AstraZeneca developing a competing pill.
Mentioned
Related Signal
Adjacent reporting
- Merck won FDA approval for the first cholesterol pill to rival powerful injectables
- FDA nod to Merck’s cholesterol pill opens a new frontier in cardiovascular care
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
- Drugmaker Merck announces approval of new cholesterol-fighting drug
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients
- FDA approves a first-of-its-kind pill to cut cholesterol in high-risk patients